Agreed, I think there are more potentials for CLME to give more public releases on a regular basis. The results of the fermentation enzyme trials would put one of the last pieces of the concept puzzle into place. After that it would seem to be an engineering / financing problem.
A previous post mentioned the rise in price as important for CLME to find investors. But with no new big ventures planned other than all the proof of concept activities, wouldn't that dilute current investments?
News 
Market Data 
Discover 
AI
